Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

ABSTRACT: scRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

PROVIDER: PRJEB63228 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR11563912_1.fastq.gz	Fastqsanger.gz
	ERR11563912_2.fastq.gz	Fastqsanger.gz
	ERR11563913_1.fastq.gz	Fastqsanger.gz
	ERR11563913_2.fastq.gz	Fastqsanger.gz
	ERR11563914_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 64

Similar Datasets

scRNA-seq of stromal, tumor and immune cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed 10x single cell RNA-seq on sorted populations: T cell (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+), fibroblasts (7AAD- Calcein Blue+ CD45- THY1.1- CD31- PDPN+), myeloid cells (7AAD- Calcein Blue+ CD45+ THY1.1- CD11b+) and tumor cells (7AAD- Calcein Blue+ CD45- THY1.1+) from cells in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13072 | biostudies-arrayexpress

Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed bulk RNA sequencing on sorted T cells (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+) in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13079 | biostudies-arrayexpress

ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:We performed 10x single cell RNA and VDJ sequencing on sorted T cells (7AAD- Calcein blue+ CD45+ THY1.1- TCRb+) in an orthotopic EMT6 tumor model 7 days after treatment initiation in four experimental groups: 1) Control 2) aPD-L1 3) aTGFb 4) aPD-L1 and aTGFb.

2023-06-30 | E-MTAB-13073 | biostudies-arrayexpress

ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:ScRNA/TCR-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

| PRJEB63367 | ENA

Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

Project description:Bulk RNA-seq of T cells from EMT6 tumors treated with aTGFb/aPD-L1

| PRJEB63259 | ENA

Gene expression changes in mouse breast tumor tissue (EMT6) after anti-PD-L1 resistance

Project description:RNA sequencing analysis was used to identify changes in mouse breast tumor tissues (EMT6) resistant to anti-PD-L1 (PDR).

2024-10-14 | GSE186032 | GEO

Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

Project description:RNA sequencing analysis was used to identify changes in mouse breast cancer (EMT6) following prolonged anti-PD-L1 in vitro (PDRvitro).

2024-10-14 | GSE186034 | GEO

EMT6 3D CS-E

Project description:Mouse EMT6 breast cancer cells were grown in 3D Matrigel culture. Effects of the glycosaminoglycan chondroitin sulfate-E (CS-E) versus untreated controls on transcriptional programs was investigated.

2014-08-01 | E-MTAB-2645 | biostudies-arrayexpress

PD-L1 checkpoint blockade promotes regulatory T-cell suppressive capacity underlying immunotherapy resistance

Project description:Transcriptome analyses of isotype-treated and aPD-L1-treated CD4+ T-cells, PD1- Treg cells and PD1+ Treg cells from a mouse model for mesothelioma.

2023-06-12 | GSE176250 | GEO

Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

Project description:Gene expression changes in mouse breast cancer cells (EMT6) after anti-PD-L1 treatment

| PRJNA772174 | ENA